These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3590069)

  • 21. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [It is beneficial to report adverse effects].
    Astrup KG; Jensen K
    Ugeskr Laeger; 1993 Jun; 155(26):2074-6. PubMed ID: 8328058
    [No Abstract]   [Full Text] [Related]  

  • 23. Centre for Adverse Reactions Monitoring report for the year ending 30 June, 1994.
    Pillans PI; Coulter DM
    N Z Med J; 1995 Nov; 108(1012):488-91. PubMed ID: 8538979
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 25. Centre for Adverse Reactions Monitoring report for the year ending 30 June, 1993.
    Pillans PI; Coulter DM
    N Z Med J; 1994 Nov; 107(990):490-3. PubMed ID: 7970369
    [No Abstract]   [Full Text] [Related]  

  • 26. Sexual dysfunction as a suspected drug reaction reported to WHO Collaborating Centre for International Drug Monitoring.
    Lundberg PO; Biriell C
    Therapie; 1993; 48(5):457-9. PubMed ID: 8146824
    [No Abstract]   [Full Text] [Related]  

  • 27. [Adverse effects of drugs--25 years later].
    Poulsen HE
    Ugeskr Laeger; 1997 Aug; 159(33):4964. PubMed ID: 9281208
    [No Abstract]   [Full Text] [Related]  

  • 28. Preventing adverse drug reactions in the general population.
    Pezalla E
    Manag Care Interface; 2005 Oct; 18(10):49-52. PubMed ID: 16265935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Pharmacovigilance: theoretical and practical aspects].
    Paoletti V; Galeotta G; Mammarella A
    Clin Ter; 1997 Mar; 148(3):67-73. PubMed ID: 9377842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The battle against adverse effects of drugs goes on. Comments to a survey].
    Boréus L
    Lakartidningen; 2004 Mar; 101(11):1016-8. PubMed ID: 15055125
    [No Abstract]   [Full Text] [Related]  

  • 31. [Notification of adverse drug-effects].
    Sven Farm Tidskr; 1965 Sep; 69(27):798. PubMed ID: 5869371
    [No Abstract]   [Full Text] [Related]  

  • 32. Adverse drug reaction monitoring in pediatric practice.
    Kshirsagar NA; Karande S
    Indian Pediatr; 1996 Dec; 33(12):993-8. PubMed ID: 9141798
    [No Abstract]   [Full Text] [Related]  

  • 33. [Adverse effects and insufficient information in Fass].
    Ekholm ML
    Lakartidningen; 2007 Jul 25-Aug 7; 104(30-31):2179. PubMed ID: 17824377
    [No Abstract]   [Full Text] [Related]  

  • 34. [Adverse psychological drug effects. Methodological problems in detection and examples from clinical practice].
    Hollweg M; Krupinski M; Steinwachs A
    Med Monatsschr Pharm; 1997 Feb; 20(2):36-43. PubMed ID: 9132536
    [No Abstract]   [Full Text] [Related]  

  • 35. Ocular adverse drug reactions and the National Registry of Drug-Induced Ocular Side Effects.
    Fraunfelder FW
    Insight; 2004; 29(2):7-11. PubMed ID: 15709350
    [No Abstract]   [Full Text] [Related]  

  • 36. [Significance of the adverbs used to indicate the incidence of the adverse effects of a drug].
    Marion MH; Simon P
    Therapie; 1984; 39(1):62-3. PubMed ID: 6463947
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse reaction assessment in Thailand.
    Sriwatanakul K; Pothisiri P
    Med Toxicol; 1986; 1 Suppl 1():105-9. PubMed ID: 3821423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Aspects of the adverse effects of drugs seen in an internal medicine clinic].
    Bălăcescu C
    Viata Med Rev Inf Prof Stiint Cadrelor Medii Sanit; 1983 Jun; 31(6):133-5. PubMed ID: 6414173
    [No Abstract]   [Full Text] [Related]  

  • 39. [The Medical Products Agency suggests improved drug safety follow-ups. New grasps of better knowledge and adverse effects reporting].
    Sjölin-Forsberg G; Lindeskog B; Lundqvist KM; Feltelius N; Alvan G
    Lakartidningen; 2007 Apr 18-24; 104(16):1226-9. PubMed ID: 17536352
    [No Abstract]   [Full Text] [Related]  

  • 40. [Interactions and adverse drug reactions: how to obtain information].
    Fattinger KE
    Praxis (Bern 1994); 1999 Apr; 88(16):713-8. PubMed ID: 10355337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.